Invesco Pharmaceuticals ETF
PJP
82 hedge funds and large institutions have $65M invested in Invesco Pharmaceuticals ETF in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 23 increasing their positions, 26 reducing their positions, and 17 closing their positions.
2.09% less ownership
Funds ownership: 16.87% → 14.78% (-2.1%)
12% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 26
13% less capital invested
Capital invested by funds: $74.5M → $65M (-$9.49M)
13% less funds holding
Funds holding: 94 → 82 (-12)
71% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 17
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$2.04M |
| 2 |
Citigroup
New York
|
+$464K |
| 3 |
Chevy Chase Trust
Bethesda,
Maryland
|
+$204K |
| 4 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
+$187K |
| 5 |
FDCDDQ
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
|
+$187K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$7.41M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.09M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.37M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$950K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$637K |
PJP Hedge Fund Activity: Q4 2021 in Review
82 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q4 2021, worth a combined $65M — down 13% from $74.5M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of PJP and 5 opened new positions — a net loss of 12 holders — while 26 trimmed existing stakes and 23 added.
The largest buyer was Wells Fargo, adding an estimated $2.04M. The largest seller was Wellington Management Group, exiting entirely with an estimated $7.41M sold.
- 82 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q4 2021, down from 94 in Q3 2021.
- Funds reported $65M of Invesco Pharmaceuticals ETF stock for Q4 2021, down 13% quarter-over-quarter.
- 5 funds opened new Invesco Pharmaceuticals ETF positions in Q4 2021 and 17 closed out, a net change of -12 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q4 2021 was Wells Fargo, an estimated $2.04M added.
- The largest Invesco Pharmaceuticals ETF seller in Q4 2021 was Wellington Management Group, an estimated $7.41M sold.
Based on aggregated 13F filings for Q4 2021.